Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Salicylate SCHEMBL28135754 | 0.80 | TSHR (0.34) | KMT2ATSHR | |
| Benzoic Acid SCHEMBL15657396 | 0.74 | CA2 (0.46) | POLBOPRD1TSHR | |
| SCHEMBL28189279 | 0.73 | GNAI3 (0.34) | — | |
| SCHEMBL27888790 | 0.73 | GNAI3 (0.34) | — | |
| SCHEMBL7527875 | 0.73 | GNAI3 (0.34) | — | |
| Urea SCHEMBL6942842 | 0.73 | GNAI3 (0.34) | — | |
| Ammonia Solution, Strong SCHEMBL28242181 | 0.73 | GNAI3 (0.34) | — | |
| Nitrogen SCHEMBL20898038 | 0.72 | GNAI3 (0.33) | — | |
| Paraben SCHEMBL2591112 | 0.70 | CA2 (0.44) | POLBOPRD1KMT2ATSHR | |
| Glycerin SCHEMBL9450682 | 0.70 | GNAI3 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033248-A1 | COMPOSITIONS AND METHODS FOR ENHANCED DECONTAMINATION | PARVINI AMIR REZA SALAR (US) | 2023-02-02 | — | — | US | disclosed |
| EP-3897704-A1 | TOPICAL FORMULATIONS FOR THE DELIVERY OF MICROBIALLY DERIVED MATERIALS | Matrisys Bioscience, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| CN-108473484-B | Compounds useful as TRPM8 modulators | 弗门尼舍公司 | 2021-06-29 | — | — | CN | disclosed |
| EP-3356356-B1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | FIRMENICH INCORPORATED (US) | 2021-05-26 | — | — | EP | disclosed |
| US-10980510-B2 | Ultrasound probe couplers and related methods | Scully, Casey K. (US) | 2021-04-20 | — | — | US | disclosed |
| WO-2020131997-A1 | TOPICAL FORMULATIONS FOR THE DELIVERY OF MICROBIALLY DERIVED MATERIALS | MATRISYS BIOSCIENCE, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| US-20200093785-A1 | SKIN CARE COMPOSITIONS AND METHODS | STAUFF DEIDRA (US) | 2020-03-26 | — | — | US | disclosed |
| US-20190336434-A1 | Antiperspirant Formulation Containing Non-Aluminum Metal And Essential Oil | GULBRANDSEN TECHNOLOGIES, INC. (US) | 2019-11-07 | — | — | US | disclosed |
| EP-3563824-A1 | ANTIPERSPIRANT FORMULATION CONTAINING NON-ALUMINUM METAL AND ESSENTIAL OIL | Gulbrandsen Technologies, Inc. (US) | 2019-11-06 | — | — | EP | disclosed |
| US-10392371-B2 | Compounds useful as modulators of TRPM8 | SENOMYX, INC. (US) | 2019-08-27 | — | — | US | disclosed |
| US-20080175875-A1 | COSMETIC COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-07-24 | — | — | US | disclosed |
| WO-2008039466-A1 | COSMETIC COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-04-03 | — | — | WO | disclosed |
| WO-2007136586-A2 | PERSONAL CARE COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070269392-A1 | Personal care compositions | Covation Inc. | 2007-11-22 | — | — | US | disclosed |
| EP-1501468-A1 | RINSABLE SKIN CONDITIONING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2005-02-02 | — | — | EP | disclosed |
| US-6699488-B2 | OIL IN WATER EMULSION HAVING HIGH DEPOSITION EFFICIENCY, SURFACTANT FREE | THE PROCTER & GAMBLE COMPANY | 2004-03-02 | — | — | US | disclosed |
| WO-2003094866-A1 | RINSABLE SKIN CONDITIONING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-11-20 | — | — | WO | disclosed |
| WO-2003094867-A1 | RINSABLE SKIN CONDITIONING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-11-20 | — | — | WO | disclosed |
| US-20030211069-A1 | Rinsable skin conditioning compositions | THE PROCTER & GAMBLE COMPANY | 2003-11-13 | — | — | US | disclosed |
| US-20030211061-A1 | Rinsable skin conditioning compositions | THE PROCTER & GAMBLE COMPANY | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10392371-B2 | Compounds useful as modulators of TRPM8 | TRPM8, TRPM4, TRPM6 | POLB 4609/4885OPRD1 223/4885KMT2A 3630/4885 |
| US-20080175875-A1 | COSMETIC COMPOSITIONS | POLE3, POLD3, PARG | POLB 266/4885OPRD1 2902/4885KMT2A 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.